Skip to Content

MYLAN 2020 MYLAN 2020 (Piroxicam 20 mg)

Pill imprint MYLAN 2020 MYLAN 2020 has been identified as Piroxicam 20 mg.

Piroxicam is used in the treatment of pain; rheumatoid arthritis; osteoarthritis; temporomandibular joint disorder; frozen shoulder and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Piroxicam 20 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Piroxicam 20 mg MYLAN 2020 MYLAN 2020
Piroxicam 20 mg MYLAN 2020 MYLAN 2020
Piroxicam 20 mg MYLAN 2020 MYLAN 2020
MYLAN 2020
MYLAN 2020
20 mg
16.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0743 UDL Laboratories Inc
68115-0282 Dispensexpress Inc (repackager)
49999-0074 Lake Erie Medical and Surgical Supply (repackager)
66267-0168 Nucare Pharmaceuticals Inc (repackager)
21695-0285 Rebel Distributors Corp (repackager)
16590-0188 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.